| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |